Bank Of Montreal Bio Xcel Therapeutics, Inc. Transaction History
Bank Of Montreal
- $197 Billion
- Q2 2024
A detailed history of Bank Of Montreal transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 31,308 shares of BTAI stock, worth $20,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,308
Previous 42,108
25.65%
Holding current value
$20,976
Previous $118,000
66.1%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BTAI
# of Institutions
75Shares Held
7.22MCall Options Held
101KPut Options Held
205K-
Armistice Capital, LLC New York, NY2.99MShares$2 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA970KShares$650,1880.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$295,2580.0% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$178,7010.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA204KShares$136,4220.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $18.8M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...